We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Testing services for individuals has now closed. To find out how to report COVID-19 results for your organisation, see the testing for organisations link below.
Information for those who have been prescribed Molnupiravir.
Information for parents of eligible children aged 6 months to 11 years on COVID-19 vaccination.
Information on ammonia (also known as hydrogen nitride), for use in responding to chemical incidents.
Guidance for data providers on submitting HPV, MenACWY and Td/IPV vaccine coverage data via ImmForm.
UKHSA leads national and global efforts to combat antimicrobial resistance (AMR) by integrating its scientific, public health, and research capabilities to deliver evidence-based interventions and innovation.
Information on xylene, for use in responding to chemical incidents.
This document clarifies the roles and responsibilities of different organisations relating to zoonotic incidents.
UKHSA responds to incidents involving non-native or invasive vector species, as well as vector-borne diseases not usually found in the UK. Each incident presents novel vector-borne disease risks and requires entomological ex…
Advice to help lower the chance of passing mpox infection to others during post-exposure vaccination clinics.
Lujo virus infection can lead to an acute viral haemorrhagic fever (VHF).
This slide deck raises awareness of the health impacts of cold weather so that organisations with responsibility for protecting health can take action.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
This notice is issued under the requirements of the UK GDPR to advise how personal data is processed for the National Registry for Radiation Workers.
Pilot study to evaluate the value of occupational health data to improve the quality of the estimate of health effects from radiation exposure in the NRRW
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
This survey monitors the distribution of a rarer tick species found in the UK called Dermacentor reticulatus (ornate cow ticks).
Community and educational approaches include nature-based solutions and climate literacy initiatives. They can help people build resilience and process emotions.
The UK Health Security Agency has introduced active surveillance of C. difficile strains circulating in England.
Some occupational groups may be at increased risk of mental health impacts associated with extreme weather.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).